In docetaxel-resistant and paclitaxel-resistant triple-negative breast cancer cells, aurora kinase A (AURKA) is highly expressed in the cells, where it mediates TGF-β-induced EMT and produces resistance to these drugs [119]. The gene discussed is AURKA; the disease is triple-negative breast carcinoma.